Skip to content

Risk Communication in African American Smokers

Nicotine Dependence and Lung Cancer Genetics in African Americans

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04084561
Enrollment
166
Registered
2019-09-10
Start date
2018-09-01
Completion date
2022-04-01
Last updated
2023-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Brief summary

The study aims to understand the effects of learning about one's genetic risk for lung cancer that is specific to their ancestry. Participants will be given hypothetical personalized genetic risk results and ask to think about how they might respond to such information if they actually received such results.

Detailed description

The study aims to understand the effects of learning about one's genetic risk for lung cancer that is specific to their ancestry. Smokers will be randomized to receive hypothetical information about their genetic status and consider how they think they would respond if such results were actually presented to them. They will be randomly assigned to receive one of four sets of hypothetical genetic results: 1) High risk of lung cancer and high genetic African ancestry, 2) High risk of lung cancer and low genetic African ancestry, 3) Low risk of lung cancer and high genetic African ancestry, or 4) Low risk of lung cancer and low genetic African ancestry. After being given this hypothetical information, participants will complete brief questionnaires assessing perceived risk of lung cancer, worry about cancer, psychological distress, and motivation to quit smoking.

Interventions

BEHAVIORALHRHA

participants will be asked to consider a hypothetical scenario in which genetic test results reveal that: 1) they carry genotypes that place African American smokers at a particularly high (\ 50%-80%) risk for the development of lung cancer, and 2) their genetic profile reflects a particularly high concordance with African heritage (\ 90%).

BEHAVIORALLRLA

participants will be asked to consider a scenario in which genetic test results reveal that: 1) they are at normal (\ 7%-10%) risk for the development of lung cancer, and 2) their genetic profile reflects a particularly low concordance with African heritage (\ 10%).

BEHAVIORALHRLA

participants will receive High Risk, Low Ancestry (HRLA) hypothetical

BEHAVIORALLRHA

participants will receive Low Risk, High Ancestry (HRLA) hypothetical

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
Temple University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 years of age minimum * Self-report African American * Report smoking at least 100 lifetime cigarettes

Exclusion criteria

* Report history of cancer

Design outcomes

Primary

MeasureTime frameDescription
Motivation to Quit Smoking1 minute after interventionuse self report 7 item (condition options) MTSS (Motivation to Stop Smoking) Scale with yes/no option to determine the quitting intention condition; range of scale : 1-7, with higher score means higher motivation to quit smoking

Countries

United States

Participant flow

Recruitment details

Because of COVID, and with the consent of the funding agency and IRB, we opened a second IRB to JUST do Aim 3. So Aim 3 is independent and it is the only part that was a clinical trial. This sample consisted of 166 respondents.

Pre-assignment details

Aim3 was the clinical trial component. We were initially informed by clinical trials staff that we should include enrollment numbers for ALL of the aims. Then we were informed to include only those recruited to Aim 3. Although the original goal was to recruit participants from Aims 1 and 2 to do Aim 3, COVID-19 made that impossible. Thus, with consent of the funding agency and IRB, we pivoted to collect the Aim 3 data remotely in an independent sample. This sample consisted of 166 respondents.

Participants by arm

ArmCount
HRHA
High Risk, High Ancestry HRHA: participants will be asked to consider a hypothetical scenario in which genetic test results reveal that: 1) they carry genotypes that place African American smokers at a particularly high (\ 50%-80%) risk for the development of lung cancer, and 2) their genetic profile reflects a particularly high concordance with African heritage (\ 90%).
41
LRLA
Low Risk, Low Ancestry LRLA: participants will be asked to consider a scenario in which genetic test results reveal that: 1) they are at normal (\ 7%-10%) risk for the development of lung cancer, and 2) their genetic profile reflects a particularly low concordance with African heritage (\ 10%).
40
HRLA
High Risk, Low Ancestry HRLA: participants will receive High Risk, Low Ancestry (HRLA) hypothetical
43
LRHA
Low Risk, High Ancestry LRHA: participants will receive Low Risk, High Ancestry (HRLA) hypothetical
42
Total166

Baseline characteristics

CharacteristicHRHALRLAHRLALRHATotal
Age, Continuous42.80 Years
STANDARD_DEVIATION 13.478
43.24 Years
STANDARD_DEVIATION 13.821
41.58 Years
STANDARD_DEVIATION 15.462
37.62 Years
STANDARD_DEVIATION 14.629
41.28 Years
STANDARD_DEVIATION 14.428
Race/Ethnicity, Customized
African Americans
41 Participants40 Participants43 Participants42 Participants166 Participants
Sex: Female, Male
Female
26 Participants24 Participants25 Participants27 Participants102 Participants
Sex: Female, Male
Male
15 Participants16 Participants18 Participants15 Participants64 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 410 / 400 / 430 / 42
other
Total, other adverse events
0 / 410 / 400 / 430 / 42
serious
Total, serious adverse events
0 / 410 / 400 / 430 / 42

Outcome results

Primary

Motivation to Quit Smoking

use self report 7 item (condition options) MTSS (Motivation to Stop Smoking) Scale with yes/no option to determine the quitting intention condition; range of scale : 1-7, with higher score means higher motivation to quit smoking

Time frame: 1 minute after intervention

ArmMeasureValue (MEAN)Dispersion
HRHAMotivation to Quit Smoking4.95 units on a scaleStandard Deviation 0.296
LRLAMotivation to Quit Smoking3.30 units on a scaleStandard Deviation 0.254
HRLAMotivation to Quit Smoking5.49 units on a scaleStandard Deviation 0.261
LRHAMotivation to Quit Smoking4.52 units on a scaleStandard Deviation 0.284

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026